Neural Mechanisms for Stopping Ongoing Speech Production
1 other identifier
interventional
30
1 country
1
Brief Summary
Speech and communication disorders often result in aberrant control of the timing of speech production, such as making improper stops at places where they should not be. During normal speech, the ability to stop when necessary is important for maintaining turn-taking in a smooth conversation. Existing studies have largely investigated neural circuits that support the preparation and generation of speech sounds. It is believed that activity in the prefrontal and premotor cortical areas facilitates high-level speech control and activity in the ventral part of the sensorimotor cortex controls the articulator (e.g. lip, jaw, tongue) movements. However, little is known about the neural mechanism controlling a sudden and voluntary stop of speech. Traditional view attributes this to a disengagement of motor signals while recent evidence suggested there may be an inhibitory control mechanism. This gap in knowledge limits our understanding of disorders like stuttering and aphasia, where deficits in speech timing control are among the common symptoms. The overall goal of this study is to determine how the brain controls the stopping of ongoing speech production to deepen our understanding of speech and communication in normal and impaired conditions.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Dec 2015
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 8, 2015
CompletedFirst Submitted
Initial submission to the registry
May 11, 2023
CompletedFirst Posted
Study publicly available on registry
May 26, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 30, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
November 30, 2027
October 8, 2024
October 1, 2024
12 years
May 11, 2023
October 3, 2024
Conditions
Outcome Measures
Primary Outcomes (1)
Mean Change in Neural Activity
The mean change in neural activity is calculated as the average change in neural activity across trials between a time period (\~1 second) after the visual cue and a time period (\~1 second) before the visual cue. Included neural activity is within the 30-minute period of cue viewing and speech production tasks.
During inpatient hospitalization, up to 14 days after surgical electrode implantation
Secondary Outcomes (1)
Number of sites with stimulation induced speech termination
During inpatient hospitalization, up to 14 days after surgical electrode implantation
Study Arms (1)
Voice and Electrocorticography (ECoG) recording during Speech Production Tasks
EXPERIMENTALParticipants produce speech following visual cues on a computer while ECoG signals for neural activity and voice was recorded during their inpatient hospitalization at the University of California, San Francisco (UCSF).
Interventions
View visual cues and undergo speech production for 30 minutes. Electrical stimulation of speech related brain regions in the middle of speech production.
Eligibility Criteria
You may qualify if:
- Participants with medication refractory epilepsy at UCSF undergoing surgical electrode implantation of subdural electrode arrays to define their seizure focus and
- Participants with electrodes implanted who are willing and able to cooperate with study tasks.
You may not qualify if:
- Participants who lack capacity,
- Participants who decline to provide informed consent or
- Participants with cognitive deficits that preclude reliable completion of study tasks.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of California, San Francisco
San Francisco, California, 94143, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Lingyun Zhao, PhD
University of California, San Francisco
- STUDY CHAIR
Edward F Chang, MD
University of California, San Francisco
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- BASIC SCIENCE
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 11, 2023
First Posted
May 26, 2023
Study Start
December 8, 2015
Primary Completion (Estimated)
November 30, 2027
Study Completion (Estimated)
November 30, 2027
Last Updated
October 8, 2024
Record last verified: 2024-10
Data Sharing
- IPD Sharing
- Will not share